European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline ; volume:24 ; number:1 ; day:11 ; month:4 ; year:2023 ; pages:1-12 ; date:12.2023
The journal of headache and pain ; 24, Heft 1 (11.4.2023), 1-12, 12.2023
- Creator
-
Lampl, Christian
Versijpt, Jan
Amin, Faisal Mohammad
Deligianni, Christina I.
Gil-Gouveia, Raquel
Jassal, Tanvir
MaassenVanDenBrink, Antoinette
Ornello, Raffaele
Paungarttner, Jakob
Sanchez-del-Rio, Margarita
Reuter, Uwe
Uluduz, Derya
Vries, Tessa de
Zeraatkar, Dena
Sacco, Simona
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-023-01573-6
- URN
-
urn:nbn:de:101:1-2023082309393684985920
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lampl, Christian
- Versijpt, Jan
- Amin, Faisal Mohammad
- Deligianni, Christina I.
- Gil-Gouveia, Raquel
- Jassal, Tanvir
- MaassenVanDenBrink, Antoinette
- Ornello, Raffaele
- Paungarttner, Jakob
- Sanchez-del-Rio, Margarita
- Reuter, Uwe
- Uluduz, Derya
- Vries, Tessa de
- Zeraatkar, Dena
- Sacco, Simona
- SpringerLink (Online service)
Other Objects (12)
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Randomized controlled trials: a critical re-appraisal
Randomized controlled trials—a critical re-appraisal
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Debate: Are cluster headache and migraine distinct headache disorders?
Intraductal carcinoma of the prostate: a critical re-appraisal
Migraine headache and labor market outcomes
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Randomized controlled trials: a critical re-appraisal
Randomized controlled trials—a critical re-appraisal
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Debate: Are cluster headache and migraine distinct headache disorders?
Intraductal carcinoma of the prostate: a critical re-appraisal
Migraine headache and labor market outcomes
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Randomized controlled trials: a critical re-appraisal
Randomized controlled trials—a critical re-appraisal
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Debate: Are cluster headache and migraine distinct headache disorders?
Intraductal carcinoma of the prostate: a critical re-appraisal